DanielPelletierMD

Associate Professor, Neurology, Yale University School of Medicine

Are you Dr. Pelletier?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 48 invites waiting!
Read the latest clinical news, personalized to your specialty.

Office
1520 San Pablo St
Suite 3000
Los Angeles, CA 90033
Phone+1 323-442-5710

Fax+1 203-737-6375

Dr. Daniel Pelletier, MD is a neurologist in Los Angeles, California. He is currently licensed to practice medicine in California, Michigan, and Connecticut. He is affiliated with Keck Hospital of USC and USC Norris Comprehensive Cancer Center.

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Vitamin D Supplementation in Multiple Sclerosis Start of enrollment: 2012 Mar 01
Completed
Phase 3

PubMed

Reliability of Central Vein Sign Imaging With 3T FLAIR* in a Multicenter Study.
Melissa Lynne Martin, Quy Cao, Elaina Luskin, Brian Renner, Lynn Daboul
Journal of Neuroimaging. 2025-01-22
Incorporation of the central vein sign into the McDonald criteria.
Moein Amin, Kunio Nakamura, Lynn Daboul, Carly O'Donnell, Quy Cao
Multiple Sclerosis and Related Disorders. 2025-01-01
Multicenter automated central vein sign detection performs as well as manual assessment for the diagnosis of multiple sclerosis.
Abigail R Manning, Vijay Letchuman, Melissa L Martin, Elaina Gombos, Timothy Roberts-Fitzgerald
AJNR. American Journal of Neuroradiology. 2024-09-27

MS Treatment Extends Time to First Symptom in Trial in People with Radiologically Isolated Syndrome (RIS)December 15th, 2022
Repopulation of T, B, and NK Cells Following Alemtuzumab Treatment in Relapsing-Remitting Multiple SclerosisJune 15th, 2020
Phase 2 Trial Testing NurOwn Therapy for Progressive MS Adds Third Clinical SiteJuly 12th, 2019
Join now to see all